NCT05347069RecruitingPhase 4
Efficacy and Safety of Aspirin in Patients With Chronic Coronary Syndromes Without Revascularization
Source: ClinicalTrials.gov · Last updated 11 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The purpose of this study is to evaluate the efficacy and safety aspirin in patients with chronic coronary syndromes without revascularization.
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 4
- Study type
- Interventional
- Enrollment
- 2890 (estimated)
- First submitted
- 21 Apr 2022
- Start date
- 14 Jun 2022
- Primary completion date
- Mar 2030
- Lead sponsor
- Takeshi Morimoto
- Diseases
- Coronary artery disease
- NCT number
- NCT05347069
What you commit to
- Study type: Interventional · Phase 4
- Planned participants: 2890
- From 14 Jun 2022 to the primary completion date, Mar 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients undergoing antithrombotic therapy other than aspirin
- Patients scheduled for major surgical procedures that will require aspirin discontinuation
Other illness
- Patients with history of acute coronary syndromes (ACS)
- Patients with history of percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG)
- Patients with history of stroke within six months
Other
- Patients with left main trunk stenosis (≥50%)
- Patients for whom aspirin administration is mandatory
- Patients with atrial fibrillation
- Patients with contraindication of aspirin
- Patients expected to have a prognosis of 1 year or less due to comorbidities
- Women of child-bearing potential or women who have a positive pregnancy test at enrolment or randomization
- Patients who are judged by attending physicians to be inappropriate to participate in this study
Who the study is looking for
- Patients with chronic coronary syndromes with ≧50% diameter stenosis in one or more major coronary vessels/major branches on coronary CT or coronary angiography but not eligible for coronary revascularization
- Patients for whom consent can be obtained
Age in the registry: 20 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Kyoto University Hospital Coordinator of this site? Confirm its status | Kyoto | Japan | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.